Eversense 365 delivered favorable glucometrics compared to other open and closed loop systems, validating the one-year CGM’s differentiated approach and high performance New data expands on findings ...
Compared with standard care, a closed-loop insulin delivery system increased the time spent within the pregnancy-specific glucose target range between 16 and 34 weeks 6 days ’ gestation among pregnant ...
First participant enrolled in randomized control trial designed to demonstrate safety and efficacy of Insulet’s fully closed-loop automated insulin delivery system versus standard therapy Unique ...
Spending more time in glucose range could help reduce adverse pregnancy outcomes, but available closed-loop insulin delivery systems are not customized to pregnancy-specific needs. In a randomized ...
Fully Closed-Loop System Feasibility Study to be presented at Insulet Symposium and in e-Poster during ATTD 2026 Real World Evidence of Settings Optimization in Omnipod 5 Users will also be shared ...
In the study, "Closed-Loop Insulin Delivery in Type 1 Diabetes in Pregnancy: The CIRCUIT Randomized Clinical Trial," published in JAMA, researchers designed an open-label randomized clinical trial to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results